PHI with Tuberculous coxitis (Ischiophthisis)
How does this condition affect your private health insurance?
Coxitis tuberculosa, also known as tuberculosis of the hip joint or ischiophthisis, is a chronic, destructive osteoarticular form of tuberculosis affecting the hip. It is caused by Mycobacterium tuberculosis, typically via hematogenous spread from a primary lung infection. The disease often progresses insidiously, leading to gradual destruction of articular cartilage and bone, synovitis, and periarticular abscesses. Symptoms include persistent hip pain, limping, muscle atrophy, and restricted movement. If untreated, it can result in severe joint deformity, pathological dislocation, limb shortening, and significant functional impairment, profoundly impacting quality of life. Diagnosis involves imaging, biopsy, and microbiological confirmation.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several months to a year, often with insidious onset before diagnosis.
Duration of Illness (Lifetime)
Chronic, requiring 6-18 months of specific treatment, with potential lifelong sequelae.
Cost of Treatment (Initial)
High, involving extensive diagnostics (imaging, biopsy), prolonged multi-drug antitubercular therapy, and potentially surgical intervention.
Cost of Treatment (Lifetime)
Very high, encompassing long-term antitubercular drugs, potential repeated surgeries, physical rehabilitation, and management of chronic pain and disability.
Mortality Rate
Moderate to low with appropriate treatment in developed countries, but significantly higher if untreated, or in immunocompromised individuals, due to dissemination or complications.
Risk of Secondary Damages
High. Common sequelae include joint destruction, ankylosis, deformity, chronic pain, limb length discrepancy, pathological dislocation, restricted mobility, and neurological deficits. Abscesses and fistulae can also occur.
Probability of Full Recovery
Moderate. While the infection can be cured, complete recovery without any functional deficit or residual joint damage is less common, especially if diagnosis is delayed. Early and aggressive treatment improves outcomes.
Underlying Disease Risk
High, particularly immune-compromising conditions such as HIV/AIDS, malnutrition, diabetes mellitus, chronic kidney disease, and immunosuppressive therapy, which significantly increase the risk of developing tuberculosis.